- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07946861
Intramedullary Nailing for Femoral Shaft Fractures
Comparative Effectiveness Randomized Controlled Trial of Micromotion vs Non-micromotion Intramedullary Nailing for Femoral Shaft Fractures
A randomized controlled trial that is trying to find the best treatment for a severe upper leg (i.e., thigh, also known as femoral shaft) fracture. One type of treatment, which is called micromotion intramedullary (within the hollow center of the bone) nailing, is a type of nail used for thigh fracture treatments that helps to heal the bone by allowing a small amount of controlled movement. Another type, called non-micromotion intramedullary nailing, is also used to treat thigh fractures but does not include this controlled-movement feature. Both treatments are approved by the FDA but have not been directly compared to each other. Participation includes being assigned to receive either a micromotion intramedullary nail or a non-micromotion intramedullary nail. Those that participate will be randomly assigned (like a flip of a coin) to one of those treatment methods and return for standard follow-up visits. In addition to those regular clinical follow-ups, participants will complete some brief surveys/questionnaires while they are in the hospital. Research staff will also look at past medical history.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Indiana
-
Indianapolis, Indiana, Forente stater, 46202
- Rekruttering
- Indiana University Health Methodist Hospital
-
Hovedetterforsker:
- Roman Natoli, MD, PhD
-
Ta kontakt med:
- Cora F Mizimakoski, Bachelor of Science
- Telefonnummer: 317-963-5034
- E-post: cmizimak@iu.edu
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients aged 18-84 years old inclusive with a femoral shaft fracture deemed appropriate for treatment with an IMN by the treating surgeon
Exclusion Criteria:
- Not within age range
- Planned treatment with dominant implants other than IMN
- Non-ambulatory at baseline
- Fracture needs a planned-staged secondary procedure for bone defects (e.g., Masquelet)
- Any previous surgery on the index site
- Fracture fixation >28 days from injury
- Fractures that the treating surgeon indicates require any additional fixation that spans the fracture. These patients will be late ineligible
- Patients with a history of infection or a current active infection at the surgical site
- Patients undergoing revision surgery following primary fixation
- Patients undergoing femoral nailing for a pathological fracture
- Patients undergoing bone transport over an intramedullary nail
- Non-English or Non-Spanish speaking
- Prisoners or impending incarceration
- Patients unwilling or unable to participate in study protocol or follow up in the IU system for 12 months
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Standard Intramedullary Nailing
|
A rod inserted into the hollow center of a long bone to hold a broken bone in place while it heals. |
|
Eksperimentell: OrthoXel Micromotion Intramedullary Nail
|
An intramedullary nail that allows for controlled axial micromotion. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Superiority of micromotion nailing over non-micromotion IMN according to a composite outcome using a win ratio reflective of improved femoral shaft fracture healing
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Iindividual levels of the win-ratio pyramid between the micromotion nailing and non-micromotion nailing groups.
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Superiority of micromotion nailing in a subgroup of patients at high baseline risk for nonunion.
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Number of patients with Adverse Events and Complications between the Micromotion nail and standard of care intramedullary nails.
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Change in daily step count from pre-injury baseline between the micromotion nailing and non-micromotion nailing groups.
Tidsramme: From enrollment to end of treatment at about a year.
|
Daily step count, measured in steps per day, will be obtained from the Apple Health app on the participant's iPhone. Participants will download the OrthoSteps app once to transfer their Apple Health data to the study team. Step counts will be assessed at the pre-injury baseline and at each post-injury follow-up. |
From enrollment to end of treatment at about a year.
|
|
Gait balance between the two groups as calculated by the GaitMap.
Tidsramme: From enrollment to end of treatment at about a year
|
From enrollment to end of treatment at about a year
|
|
|
Walking speed using a GaitMap
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
|
|
Modified Radiographic union scores for femoral shaft fractures
Tidsramme: From enrollment to end of treatment at about a year.
|
From enrollment to end of treatment at about a year.
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Roman Natoli, MD, PhD, Indiana University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 29753
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .